| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.5767 | 16 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.2889 | 33 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.9775 | 17 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.8067 | 17 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.8138 | 31 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.0007 | 22 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.4173 | 15 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.8171 | 31 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.6076 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.7623 | 40 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.9959 | 22 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.6042 | 25 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.5298 | 35 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 40.3448 | 7 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 39.3962 | 5 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.8092 | 21 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.8152 | 40 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.1126 | 45 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.6923 | 26 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.0749 | 18 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.0733 | 37 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.1235 | 54 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.5382 | 11 |